key: cord-1025136-cpw1esbl
authors: Vanichkachorn, Greg; Newcomb, Richard; Cowl, Clayton T.; Murad, M. Hassan; Breeher, Laura; Miller, Sara; Trenary, Michael; Neveau, Daniel; Higgins, Steven
title: Post COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at the Mayo Clinic and Characteristics of the Initial Patient Cohort
date: 2021-05-11
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2021.04.024
sha: c02dad5b3a6f57375ce0fd11b34a73c5dbd7b9e9
doc_id: 1025136
cord_uid: cpw1esbl

Objective To describe characteristics of a series of patients reporting prolonged symptoms after an infection with COVID-19. Methods This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program (CARP), established at Mayo Clinic to evaluate and treat post-COVID-19 syndrome (PCS) patients, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020 and December 31, 2020. Results The cohort consisted of 100 patients (mean age 45 years, 68% women, BMI 30.2, presenting a mean of 93 days after infection). Common pre-existing conditions were respiratory (23%) and mental health, including depression and/or anxiety (34%.) The majority (75%) had not been hospitalized for COVID-19. Common presenting symptoms ware fatigue (80%), respiratory complaints (59%), and neurologic complaints (59%) followed by subjective cognitive impairment, sleep disturbance, and mental health symptoms. More than one-third of the patients (34%) reported difficulties with performing basic activities of daily living. Only 1 in 3 patients had returned to unrestricted work duty at the time of the analysis. For most patients, laboratory and imaging studies were normal or non-diagnostic despite debilitating symptoms. Most patients required physical therapy, occupational therapy, or brain rehabilitation. Face-to-face and virtual care delivery modalities were feasible. Conclusion Many of the patients did not experience COVID-19-related symptoms that were severe enough to require hospitalization, were younger than 65 years of age, more likely to be female, and most had no pre-existing comorbidities prior to SARS-CoV-2 infection. Symptoms including mood disorders, fatigue, and perceived cognitive impairment resulted in severe negative impacts on resumption of functional and occupational activities in patients experiencing prolonged effects.

By March 2021, an estimated 28.6 million Americans in the United States have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, with more than 500,000 deaths 1 Although efforts to vaccinate large populations globally are ongoing and the numbers of new cases have declined in some regions of the world, a wide variation in the spectrum of clinical symptoms has been documented for those infected previously -from asymptomatic individuals testing positive for the virus to others with rapidly progressive symptoms requiring hospitalization and mechanical ventilation and who may later develop respiratory failure and/or death. 2, 3 Advanced age, ethnicity, gender, race, elevated body mass index, immunosuppression, and other medical co-morbidities have been described as risk factors for severe infections requiring hospitalization. 1, [4] [5] [6] Although considerable epidemiologic data have been published for individuals who experience severe symptoms requiring inpatient care, the natural history and symptom patterns for COVID-19 patients who do not require hospitalization is just beginning to be described. 7 Prolonged symptoms have been recognized as affecting individuals in prior epidemics, such as with the coronavirus causing Severe Acute Respiratory Syndrome (SARS) outbreaks in 2003. One-third of surviving SARS patients experienced chronic dyspnea and other respiratory symptoms exceeding 12 months or more after acute infection. 8 In addition, radiographic abnormalities suggesting pulmonary fibrotic change were identified in 45% of patients one month after infection, 30-36% at 3-6 months, and 28% within one year of the initial infection. 9 Moreover, non-pulmonary symptoms also persisted, such as headaches, anxiety, depression, and myalgias.

Several studies have described COVID-19 patients with prolonged symptoms, tracking individuals who remained hospital confined or who were dismissed to the outpatient setting after being hospitalized. In

Italy, 143 hospitalized patients were surveyed approximately 60 days following symptom onset with 32%

reporting persistence of at least one to two symptoms, and 55% having three or more. The most common symptoms were fatigue and dyspnea. 10 Similarly, a Parisian study of 120 patients interviewed on average 111 J o u r n a l P r e -p r o o f days after acute infection revealed most had some form of lingering symptoms including fatigue (55%), dyspnea (42%), perceived cognitive difficulties (34%), and sleep disorders (30.8%). 11 Headache has been the most common neurological complaint (13.6%), 8 along with other non-specific subjective symptoms of concentration difficulties, subjective memory loss, reduced attention span, and even delirium, the latter noted predominantly in hospitalized populations. [12] [13] [14] [15] [16] Longer-term sequelae of SARS-CoV-2 infection involving outpatients have not been described as thoroughly. A recent longitudinal prospective cohort study 17 tracked chronic symptoms in a cohort of 234 post-COVID-19 patients residing in the Pacific Northwestern U.S. Outcomes nine months after laboratoryconfirmed SARS-CoV-2 infection found 30% of individuals were having one or more symptoms persisting nine months or longer, including 13.6% affected by generalized fatigue, another 13% with anosmia, and 13%

reporting other more nebulous symptoms such as "brain fog." Symptoms were more likely to be prolonged in older age groups.

A multidisciplinary clinic at Mayo Clinic's Rochester, Minnesota campus was developed to provide comprehensive care to post-COVID-19 individuals experiencing persistent symptoms. In this report, we outline the components and approach of this clinic and describe the initial 100 patients participating in this program. This report describes a self-referred population of patients with laboratory confirmed SARS-CoV-2

infections who developed COVID-19 and reported persistent symptoms spanning one to six months, often referred to as Post-COVID Syndrome (PCS) or "COVID long haul syndrome."

As COVID-19 patients recovering from acute illness in the spring of 2020 were recorded, many survivors of severe disease reported difficulties returning to their baseline function. In addition, patients with less severe COVID-19 cases also were noted to develop lingering and multiple symptoms even though J o u r n a l P r e -p r o o f sequential nasopharyngeal swab testing for SARS-CoV-2 had become negative. Initial efforts to assess, characterize, and treat these individuals began with an informal, multi-disciplinary team that collaborated first in April 2020. As the number of patients requesting assistance increased, by June 2020 this team was transitioned into a more structured clinic referred to as the COVID Activity Rehabilitation Program (CARP).

The program interventions were based upon treatments used for SARS/MERS and chronic fatigue syndrome, from a pool of healthcare professionals practicing within various specialty fields focused on prevention, diagnostics, and rehabilitation, as well as the limited available data published on recovery from COVID-19 patients worldwide.

The Mayo Clinic program was delivered both via face-to-face visits and/or virtually, using either video telemedicine or telephone interactions. Although there was no limit on how soon patients could participate in the clinic after infection, no CARP interventions were performed until at least four or more weeks following a positive SARS-CoV-2 PCR test and/or symptomatic start of confirmed SARS-CoV-2

infection.

There are three primary objectives of CARP. The first has been to actively assess for any associated conditions and to detect evidence for decompensation in the early recovery phase. A Michigan study of 1250 patients initially hospitalized with COVID-19 found that 84 patients had died within 60 days after discharge.

The fatality rate was higher in patients who had been admitted to an intensive care unit (10.4%) compared to those who were not (6.7%). 18 In addition, thromboembolic complications, such as deep vein thrombosis, pulmonary embolism (PE), and acute ischemic stroke have been associated with SARS-CoV-2 infection, with PE being the most common. 19, 20 The second objective has been to facilitate improvement of function. This is primarily achieved through physical and occupational therapy, focusing therapy as a customized, individually paced program, versus a step-wise graded activity approach standardized to each individual enrolled. This approach has been based upon therapeutic outcomes recorded during the SARS epidemic as well as treatment pathways used to address individuals experiencing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and is J o u r n a l P r e -p r o o f described in more detail below. [21] [22] [23] Physical therapy begins with an assessment of vital signs (blood pressure, heart rate and oxygen saturation) and a 6-minute walk test. These data, along with perceived exertion and dyspnea, help guide initial activity recommendations, which involves development of a general strengthening and conditioning program. Re-stablishing self-care routines, in particular optimizing sleep hygiene, has been the role of occupational therapists who help patients concentrate on daily structure, tempering efforts to return to full activity immediately and emphasizing individualized activity thresholds. Instruction in diaphragmatic breathing and relaxation techniques reduce the work of breathing, as well as reduce muscle tension, and assist in stress management. Psychosocial-based treatment, from both physical and occupational therapy, is used to identify and remove unique barriers for recovery and help reformulate preconceived notions of illness and disability. Job-specific testing and simulations are used to help guide appropriate work restrictions, which are managed, for the most part, by Occupational Medicine specialists.

The third objective is to facilitate a therapeutic and safe pathway for returning to work. Management of work restrictions is often an intensive process during which the provider must obtain a detailed understanding of the patient's occupation while weighing the impairing medical condition, and taking into account factors such as perceived pain, symptom magnification, catastrophizing, the patient's education level, employment rank, and fear of reinjury. 24 Management of these variables requires trust by the patient, careful communication and role clarity among multiple stakeholders, including employers, legal representatives, and insurance adjusters, in addition to the patient. 24 To meet these unique demands, CARP was staffed primarily by Occupational Medicine specialists, who have received specific training to navigate this intricate process and opine on work injury risk, tolerance, and capacity. The PT/OT component used by CARP was also adapted from the treatment of injured workers, where psychosocial-focused treatment is crucial for recovery. 25 Typical tests and consultations used in CARP are described in Table 1 . Routine lab work was performed to assess for infection, electrolyte abnormalities, and renal or hepatic dysfunction. Vitamin B-12

and Vitamin D levels were obtained to assess deficiencies. Thyroid stimulating hormone was drawn to check for fatigue related to undiagnosed hypothyroidism. To assess respiratory function, chest radiographs and J o u r n a l P r e -p r o o f spirometry were frequently performed. Complications of thromboembolic disease were assessed by lower extremity Doppler ultrasound, serum D-dimer levels, and computed tomography angiogram of the chest.

Autonomic nervous system dysfunction, including orthostatic intolerance and sudomotor dysfunction, was assessed using an autonomic reflex screen. Finally, functional ability was measured using either a 6-minute walk test or a cardiopulmonary exercise test.

Currently, there is no universal definition or label for the prolonged symptoms that may occur after 

Institutional Review Board approval was obtained prior to data collection, which was deemed minimal risk. A database of PCS patients was created which included all patients who had been evaluated in J o u r n a l P r e -p r o o f the CARP clinic. Randomized numeric aliases were generated for each patient prior to data abstraction from the medical record. No patient identifier information was collected or stored in the research database.

Patients who experienced a complete symptomatic recovery from acute SARS-CoV-2 infection less than four weeks from the start of symptoms and/or positive PCR test date were excluded from the database, as well as patients who did not have a laboratory confirmed COVID-19 PCR or SARS-CoV-2 antibody test result in the medical record.

To minimize variation, data abstraction was performed by a single team member using a standardized intake log. As an exploratory program, detailed patient interviews were utilized for initial visits; however, 

We report on the first 100 PCS patients participating in the CARP. The most common pre-existing condition category was respiratory (23%), with asthma being the most prevalent diagnosis. Other pre-existing conditions included: a history of depression or anxiety (34%), hypertension (19%), chronic fatigue syndrome (4%), and diabetes (3%). The majority (75%) of patients had not been hospitalized for SARS-CoV-2 infection. The mean BMI of the cohort was 30.2 kg/m 2 + 7.8.

The most common symptom noted on initial presentation to the program was fatigue (80%), followed by respiratory complaints (59%) and neurologic complaints (59%). The most common respiratory symptom was dyspnea (49%) and the most common neurologic symptom was headache (20%). Other common symptoms were subjective cognitive complaints, sleep disturbance, and mental health symptoms.

Altered taste/smell was an infrequent prolonged symptom in the cohort. Functionally, more than one third (34%) of CARP patients reported having difficulties with performing ADLs and 84% of patients reported trouble with household chores, exercise, driving and/or completing tasks required at work.

With the primary goal of restoring function and returning to work, occupational data were collected and tabulated in Table 3 . Prior to their infection, 91% of the cohort was employed and 63 patients had returned to some form of gainful employment at the time of presentation to CARP. However, of the 63 patients who had returned to work, only 46% had returned to unrestricted work duty at the time of presentation to the CARP. At initial intake, 31% of employed patients (28 of 91 patients) had not returned to work in any capacity after their SARS-CoV-2 infection. Table 3 also describes several differences between those who return to full-time unrestricted work duty compared to the remainder of the patients.

Diagnostic testing volumes are outlined in Table 4 

This study describes the first 100 patients seen in one of the first multidisciplinary programs focused on PCS, also termed "long haul COVID-19." An important finding is that the CARP PCS population appears distinct from those who suffer more severe cases of acute SARS-CoV-2 infection. While advanced age and the presence of several comorbidities are positively associated with increased mortality and hospitalization during acute infections, CARP patients were younger (mean age 45.4 years old + 14.2) than groups associated with severe infection, high mortality, and hospitalization. 27 In addition, most PCS patients had no significant J o u r n a l P r e -p r o o f medical conditions prior to their SARS-CoV-2 infection, making it difficult to predict which patients may be at risk for PCS. It is also notable that females outnumbered males roughly 3:1, despite male gender being associated with poorer acute COVID-19 outcomes. 28 Female gender preponderance is seen with other post viral syndromes. 29 Unfortunately, this descriptive study does not include enough data to hypothesize for this gender difference.

Consistent with other studies, fatigue and dyspnea were the most common complaints seen in the CARP. However, self-reported cognitive difficulty, anxiety, depression, and insomnia were also common.

Patients reported that their cognitive and mood symptoms were often minimized or dismissed by healthcare providers, which is concerning since many PCS symptoms are similar to prolonged sequela following traumatic brain injury for which prolonged or permanent inability to return to work has been recorded. [30] [31] [32] As an initial observational study, it is too early to determine the full impact of symptoms and treatment on an individual's ability to return to work. However, the results do provide impetus for a thorough assessment and consideration of all symptoms and their impact on functional capacity both at work and home. Patient and provider concern for PCS impact on ADLs and work was common in this initial cohort, noting that the prolonged average time to presentation being roughly three months after acute infection is troublesome, and suggesting the presence of prolonged workplace absenteeism with PCS.

CARP patients underwent multiple tests, most of which were normal or non-diagnostic. This is in contrast with other published studies, which have reported a high prevalence of abnormal results, especially echocardiographic and cardiac MRI data. 33 These findings underscore that diagnostic testing should be performed judiciously, and that clinically significant symptoms may not be explained solely by diagnostic In terms of treatments used in the program, brain rehabilitation was offered to some patients due to evidence suggesting that active recovery is more effective for concussion treatment when compared to complete physical and mental rest. 36 37 Physical/occupational therapy was frequently employed since research from the SARS and MERS epidemics showed that these modalities were associated with improvements in function. 23, 38 In addition, research from both the SARS/MERS epidemics and ME/CFS indicates that in some post viral syndromes, excessive activity can result in prolonged worsening of symptoms and function. 39, 40 Finally, psychosocial support of patients was heavily emphasized. CARP patients frequently reported feelings of abandonment, guilt, and frustration during initial evaluation, and 26% reported increased anxiety and depression symptoms compared to baseline before SARS-CoV-2 infection. Psychosocial support included referrals to counseling, use of employee assistance programs, and referral to psychiatrists or other mental health professionals.

The CARP has focused on functional abilities that include returning to work, demonstrating an opportunity for healthcare professionals to recognize the impact on this important social determinant of health in patients. This case series is limited in drawing any population-based conclusions involving PCS patients due to its small initial sample size and the fact that this was a self-referred convenience sample.

Although the initial cohort reported was predominately female and < 45 years of age, this may represent a J o u r n a l P r e -p r o o f 

Prevention CfDCa. COVID Data Tracker

COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study

Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare System

COVID-19 Hospitalization by Race and Ethnicity: Association with Chronic Conditions Among Medicare Beneficiaries

Characteristics and Factors Associated with SARS-CoV-2 infection, Hospitalization, and Mortality Across Race and Ethnicity

Factors associated with hospitalization, invasive mechanical ventilation treatment and death among all confirmed COVID-19 cases in Norway: Prospective cohort study

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

The Stanford Hall consensus statement for post-COVID-19 rehabilitation

Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19)

Persistent Symptoms in Patients After Acute COVID-19

Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19

The 'third wave': impending cognitive and functional decline in COVID-19 survivors

Should we mind for late neurologic manifestations from novel coronavirus?

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

The Neurologic Manifestations of Coronavirus Disease

Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review

Sequelae in Adults at 6 Months After SARS-CoV-2 infection

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19

Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys

A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome

Influence of Psychosocial and Sociodemographic Variables on Sickness Leave and Disability in Patients with Work-Related Neck and Low Back Pain

Returning to work following low back pain: towards a model of individual psychosocial factors

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection

Associations between insomnia, sleep duration and poor work ability

Factors associated with quality of life and work ability among Finnish municipal employees: a cross-sectional study

Quality of return to work in patients with mild traumatic brain injury: a prospective investigation of associations among post-concussion symptoms, neuropsychological functions, working status and stability

Global evaluation of echocardiography in patients with COVID-19

A case report of postural tachycardia syndrome after COVID-19

New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease

Active Rehabilitation of Concussion and Post-concussion Syndrome

Active recovery from concussion

Rehabilitation to enable recovery from COVID-19: a rapid systematic review

Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey

Considerations for Postacute Rehabilitation for Survivors of COVID-19

The authors express their gratitude to the COVID Front Line Care Team at the Mayo Clinic for their assistance. The authors have no conflicts of interest to disclose.

In the interest of transparency, we ask you to disclose all relationships/activities/interests listed below that are related to the content of your manuscript. "Related" means any relation with for-profit or not-for-profit third parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a relationship/activity/interest, it is preferable that you do so.The following questions apply to the author's relationships/activities/interests as they relate to the current manuscript only.

In item #1 below, report all support for the work reported in this manuscript without time limit. For all other items, the time frame for disclosure is the past 36 months.

Specifications/Comments (e.g., if payments were made to you or to your institution) Time frame: Since the initial planning of the work 1All support for the present manuscript (e.g., funding, provision of study materials, medical writing, article processing charges, etc.) No time limit for this item. Please place an "X" next to the following statement to indicate your agreement:_X__ I certify that I have answered every question and have not altered the wording of any of the questions on this form.